The word “peptide” does not tell you whether a product builds muscle. Peptides are short chains of amino acids. That describes their structure, not a shared effect on strength, body composition or recovery.[1]
Lean mass and strength are different findings
A useful example comes from a tirzepatide weight-management study. In a body-composition substudy of 160 participants, weight loss included both fat and lean mass. About three-quarters of the weight lost was fat and one-quarter was lean mass. Those proportions were similar in the tirzepatide and placebo groups.[2]
The substudy measured body composition during weight loss using DXA. It did not test increased strength or a muscle-building treatment.[2]
What would support a muscle claim?
Human studies need a defined product and a defined question. FDA describes clinical trials as studies with planned participants, duration, measurements and methods to reduce bias. Early safety research has a different purpose from later studies designed to establish a treatment benefit.[3]
For a muscle-building claim, the relevant questions are concrete: Did researchers measure muscle size, lean mass, strength or everyday function? Was there a comparison group? Did the study involve people similar to the intended users? Were exercise and other influences accounted for?
